The effect of therapy on mature height in congenital adrenal hyperplasia.
The effect of therapy on mature height in congenital adrenal hyperplasia.
复制标题
治疗对先天性肾上腺增生症成熟身高的影响。
DOI：
--
复制
发表时间：
1978
影响因子：
5.8
通讯作者：
G. W. Clayton
中科院分区：
文献类型：
--
作者：
R. Kirkland;B. S. Keenan;J. H. Holcombe;J. L. Kirkland;G. W. Clayton
The effects of therapy on the final height of children with congenital adrenal hyperplasia (CAH) were evaluated. Forty-six children with the 21-hydroxylase defect, 30 of whom had defects in electrolyte metabolism, were followed to maturity. In group A, there were 19 children (11 females and 8 males) who were diagnosed and adequately treated at less than 3 yr of age. In group B, there were 9 children (8 females and 1 male) who were adequately treated, but treatment was begun after 3 yr of age. In group C, there were 15 children (10 females and 5 males) whose treatment was inadequate. In group D, there were 3 female pseudohermaphrodites reared as males. The mean ages at diagnosis were: group A, 0.60 yr (±0.79 sd); group B, 6.43 yr (±2.96 sd); and group C, 4.96 yr (±5.19 sd). The group A males (final height, 171.9 cm ± 2.8 se) and females (final height, 162.5 cm ± 1.6 se) were significantly taller than the corresponding group C children (males, 160.14 cm ± 2.4 se, P < 0.01; females, 145.64 cm ± 2.89 se, P < ...
